Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Fixed Capital/Sales

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.440.380.410.400.47

What is the latest Fixed Capital/Sales ratio of MARKSANS PHARMA ?

The latest Fixed Capital/Sales ratio of MARKSANS PHARMA is 0.44 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.44
Mar20230.38
Mar20220.41
Mar20210.40
Mar20200.47

How is Fixed Capital/Sales of MARKSANS PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.44
15.79
Mar2023 0.38
-7.32
Mar2022 0.41
2.50
Mar2021 0.4
-14.89
Mar2020 0.47 -

Other Financial Ratios of MARKSANS PHARMA


Compare Fixed Capital/Sales ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,761.4 Cr -2.7% -1.7% 97.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.7%

-1.7%

97.1%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses